Search for: "SCHERING-PLOUGH"
Results 361 - 380
of 404
Sort by Relevance
|
Sort by Date
23 Jul 2007, 6:58 am
Schering-Plough, 842 A.2d 174 (N.J. [read post]
20 Jul 2007, 7:39 pm
The settlement follows a ruling last month ordering Bristol Myers-Squibb, AstraZeneca Plc and Schering-Plough Corp. to pay damages for allegedly overcharging on drugs by inflating the "average wholesale price" (AWP). [read post]
4 Jul 2007, 5:16 pm
Schering-Plough Healthcare Prods., Inc. v. [read post]
28 Jun 2007, 10:16 am
Schering-Plough Corp., 842 A.2d 174, 178 (N.J. [read post]
27 Jun 2007, 10:46 am
Schering-Plough Corp., No. 05-273 (Jun. 26, 2006; denying certiorari). [read post]
26 Jun 2007, 10:01 pm
In a nationwide class action lawsuit, plaintiffs alleged that AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, and Schering-Plough sold drugs to doctors at discounted prices while encouraging them to claim full reimbursement from insurers. [read post]
24 Jun 2007, 10:12 pm
Federal judge Patti Saris ruled that pharmaceutical companies AstraZeneca, Schering-Plough and Bristol-Myers Squibb engaged in unfair and deceptive trade practices in the setting of Average Wholesale... [read post]
21 Jun 2007, 7:49 am
A federal judge in Beantown ruled that four Big Pharma companies — AstraZeneca, Schering-Plough and Bristol-Myers — engaged in unfair and deceptive trade practices regarding drug pricing. [read post]
8 Jun 2007, 12:49 pm
The FTC has challenged similar arrangements, arguing that they are anti-competitive and hurt consumers, and asked the Supreme Court to hear a case involving Schering-Plough in which a similar deal was struck. [read post]
2 Jun 2007, 11:51 pm
Four former employees of Schering-Plough Corp. [read post]
30 May 2007, 7:19 pm
By Jason Derry -- Novacea, Inc. and Schering-Plough have announced an agreement to develop and commercialize Asentar ®, which is currently in Phase III clinical trials for the treatment of prostate cancer. [read post]
25 May 2007, 8:57 am
Schering-Plough Corp., No. 05-273 (Jun. 26, 2006; denying certiorari), as well as three other recent petitions. [read post]
24 May 2007, 12:49 pm
Schering-Plough, the Solicitor General urged the Court not to grant cert. to consider whether federal antitrust laws prohibit the manufacturer of a patented brand-name drug from entering into an agreement with the manufacturer of a generic substitute to share its future profits from the sale of the brand-name drug in exchange for the generic manufacturer's agreement not to market the substitute. [read post]
24 May 2007, 10:40 am
Plough, Inc., that state law would not require warnings in Spanish where the FDA required only English language warnings:[W]e reject plaintiff's attempt to place on nonprescription drug manufacturers a duty to warn that is broader in scope and more onerous than that currently imposed by applicable statutes and regulations. the FDA has stressed that "it is in the best interest of the consumer, industry, and the marketplace to have uniformity in the presentation and clarity of… [read post]
8 May 2007, 9:02 am
Notably, in an attempt to stave off total defeat in the Schering-Plough case, the FTC had suggested that the Court hold the case pending the Second Circuit's disposition of . . . [read post]
27 Apr 2007, 10:46 am
Seton Hall Law School announced a new Center for Health and Pharmaceutical Law, endowed by Schering-Plough Corporation, sanofi-aventis, Johnson Johnson, and Bristol-Myers Squibb, as well as an expansion of the law school's Institute of Law, Science, and Technology, endowed by... [read post]
26 Apr 2007, 11:32 am
Four drugmakers — Schering-Plough, Sanofi-Aventis, Johnson & Johnson and Bristol-Myers Squibb — have ponied up a combined $8.1 million to create the center, whose mission is to create “an independent, neutral facility that can bring together representatives from industry, government and academia to discuss regulatory and public policy issues important to the industry, the government and the public. [read post]
24 Apr 2007, 8:49 am
From Ed Silverman at Pharmalot:Four big drugmakers are ponying up a combined $8.1 million to create a new center devoted to health and pharma law at Seton Hall University's law school, which is located in a New Jersey suburb about 30 minutes from Manhattan.The new Center for Health & Pharmaceutical Law is being funded by Schering-Plough, Sanofi-Aventis, Johnson & Johnson and Bristol-Myers Squibb. [read post]
24 Apr 2007, 1:04 am
If newsfeeds are shown on the left side of your screen, the News articles listed below can be viewed in full text by first clicking on the Law.Com Newsfeed and then scrolling down to the appropriate article. [read post]
23 Apr 2007, 2:25 am
Schering-Plough Sued in N.J. for Marketing Drugs for Off-Label Uses A raft of lawsuits centered in New Jersey allege Schering-Plough Corp. offered bribes, kickbacks and other incentives to doctors to get them to prescribe its hepatitis and cancer drugs for uses not approved by the Food and Drug Administration Racial-Profiling Claim Gets Priority Over State's Attenuation Argument A criminal defendant is… [read post]
